CClinicalTrials.gg
CompletedNCT04308902Updated Mar 31, 2022

OptiMoM Grows Up: 5.5-year Follow-up of the OptiMoM Fortifier Study

An observational study in Infant, Very Low Birth Weight, sponsored by The Hospital for Sick Children. Completed at 1 site in Canada. Open to participants aged 5 Years to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-31.

Sponsored by The Hospital for Sick Children · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
149
Ages
5 Years to 6 Years
Sex
All
01

Study summary

In Canada, the leading cause of long-term disability in children is being born at very low birth weight (VLBW). To help improve outcomes, nutrition is a modifiable aspect of infant care. Mother's milk is the optimal way to feed VLBW infants; however, many need a supplement of donor milk or preterm formula as not enough mother's milk is available. As the ideal supplement for prolonged feeding and its long-term effects is currently unknown, this study is a prospective follow-up of infants born VLBW who were fed mother's own milk or pasteurized donor breastmilk nutrient enriched with a human milk-based fortifier or a bovine protein-based fortifier. Intakes of donor milk, fortifier type, macronutrients and fatty acids will be explored. Areas of development to be assessed include: cognition, language, motor skills, and body composition. This study will also cross-sectionally examine aspects of eating behaviours, food parenting and the home environment (e.g., stress, home chaos, family functioning) with a term-born comparison. A DNA biorepository will also be created.

02

Conditions studied

  • Infant, Very Low Birth Weight

Browse trials for

03

In context

Birth Weight

445 studies on the registry are indexed under Birth Weight; 36 are open to participants now.

This study's enrollment of 149 is below the median of 212 across 136 observational studies indexed under Birth Weight.

Browse Birth Weight studies →

Lead sponsor

The Hospital for Sick Children is the lead sponsor of 568 studies on the registry; 81 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Very low birth weight infants previously enrolled in the Bovine vs. Human Milk-Based Fortifier Study (NCT02137473) and a comparison group of children born full-term (>=37 weeks gestation) and weighing >2500g.

Inclusion criteria

  • Children who were enrolled in the Bovine vs. Human Milk-Based Fortifier Study (NCT02137473)
  • Children who were born >=37 weeks gestation and weighing > 2500g [Term-born comparison group]

Exclusion criteria

Exclusion Criteria:

  • For term-born comparison only: a child with any chromosomal or congenital anomaly affecting growth
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
149 participants (actual)
Patient registry
No

Groups and cohorts

  • Children previously enrolled in the OptiMoM Fortifier Study

    This is an observational study of children who were previously enrolled in a trial (Bovine vs. Human Milk-Based Fortifier Study) between 2014 and 2016 during which time they were randomized to have their feeds (mother's own milk or pasteurized donor breastmilk) nutrient enriched with a human milk-based fortifier or a bovine protein-based fortifier.

    Other: VLBW

  • Term-born Comparison

    This is an observational study of children born at full term (\>= 37 weeks gestation) and weighing more than 2500g. These children will be recruited from the communities in which the OptiMoM participants live.

    Other: Term-born Comparison

Interventions

  • OtherVLBW

    Participants previously enrolled in the Bovine vs. Human Milk-Based Fortifier Study

  • OtherTerm-born Comparison

    Children born \>=37 weeks gestation and weighing more than 2500g

06

What researchers measure

Primary outcomes

  1. Full-Scale Intelligence Quotient (IQ)

    Measured using the assessor-administered Wechsler Preschool and Primary Scale of Intelligence-IV (WPPSI-IV). The WPPSI-IV Full-scale IQ and all composite sub-scales are standardized to a mean of 100, with a standard deviation of 15. Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  2. Growth

    Growth as assessed by weight in kilograms (kg) and height in meters (m) measured by trained staff to assess body mass index (BMI). BMI will be the ratio of weight (kg) to the square of height (m).

    Time frame: 5.5 years of age

Secondary outcomes

  1. Verbal Comprehension Index

    Measured using the assessor-administered Wechsler Preschool and Primary Scale of Intelligence-IV (WPPSI-IV). The WPPSI-IV composite sub-scales are standardized to a mean of 100, with a standard deviation of 15. Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  2. Visual Spatial Index

    Measured using the assessor-administered Wechsler Preschool and Primary Scale of Intelligence-IV (WPPSI-IV). The WPPSI-IV composite sub-scales are standardized to a mean of 100, with a standard deviation of 15. Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  3. Working Memory Index

    Measured using the assessor-administered Wechsler Preschool and Primary Scale of Intelligence-IV (WPPSI-IV). The WPPSI-IV composite sub-scales are standardized to a mean of 100, with a standard deviation of 15. Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  4. Fluid Reasoning Index

    Measured using the assessor-administered Wechsler Preschool and Primary Scale of Intelligence-IV (WPPSI-IV). The WPPSI-IV composite sub-scales are standardized to a mean of 100, with a standard deviation of 15. Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  5. Vocabulary Acquisition Index

    Measured using the assessor-administered Wechsler Preschool and Primary Scale of Intelligence-IV (WPPSI-IV). The WPPSI-IV composite sub-scales are standardized to a mean of 100, with a standard deviation of 15. Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  6. Processing Speed Index

    Measured using the assessor-administered Wechsler Preschool and Primary Scale of Intelligence-IV (WPPSI-IV). The WPPSI-IV composite sub-scales are standardized to a mean of 100, with a standard deviation of 15. Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  7. Body Composition

    Trained staff will measure body composition (e.g., % fat mass, % fat-free mass) using air displacement plethysmography, i.e., BODPOD™.

    Time frame: 5.5 years of age

  8. Body Composition

    Trained staff will measure body composition using bicep, tricep, subscapular and superilliac skinfold thicknesses.

    Time frame: 5.5 years of age

  9. Diet Quality

    Diet Quality as measured using the Healthy Eating Index calculated from two 24-hour recalls conducted by trained staff. Scores on the Healthy Eating Index range from 0-100 with higher scores indicated higher diet quality.

    Time frame: 5.5 years of age

  10. Waist circumference

    Trained staff will measure waist circumference (cm) at the midpoint between the top of the iliac crest and lowest rib.

    Time frame: 5.5 years of age

  11. Blood pressure

    Trained staff will measure blood pressure using an automated sphygmomanometer.

    Time frame: 5.5 years of age

Other outcomes

  1. Affect Recognition domain

    Measured using the assessor-administered Developmental Neuropsychological Assessment-Second Edition (NEPSY-II). Scaled scores for each subtest consist of a mean of 10 and a standard deviation of 3 (range of 1-19). Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  2. Inhibition domain

    Measured using the assessor-administered Developmental Neuropsychological Assessment-Second Edition (NEPSY-II). Scaled scores for each subtest consist of a mean of 10 and a standard deviation of 3 (range of 1-19). Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  3. Design Fluency domain

    Measured using the assessor-administered Developmental Neuropsychological Assessment-Second Edition (NEPSY-II). Scaled scores for each subtest consist of a mean of 10 and a standard deviation of 3 (range of 1-19). Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  4. Statue domain

    Measured using the assessor-administered Developmental Neuropsychological Assessment-Second Edition (NEPSY-II). Scaled scores for each subtest consist of a mean of 10 and a standard deviation of 3 (range of 1-19). Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  5. Visual-Motor Integration

    Measured using the assessor-administered Beery-Buktenica Developmental Test of Visual-Motor Integration (Beery VMI). Standard scores with a mean of 100 and a standard deviation of 15 will be reported. Higher scores on the Beery VMI indicate superior performance.

    Time frame: 5.5 years of age

  6. Social-Emotional Functioning

    Social-Emotional functioning as measured by parent-report using the Social Responsiveness Scale Second Edition (SRS-2). T-scores on the SRS-2 have a mean of 50 and standard deviation of 10. Higher scores are associated with more severe social impairments.

    Time frame: 5.5 years of age

  7. Behaviour and Emotional Response

    Behaviour and Emotional Response as measured by parent-report using the Behavior Assessment System for Children-Third Edition (BASC-3). Scores are expressed as T-scores with a mean of 50 and standard deviation of 10. Higher values indicate increased risk for composites of clinical scales and lower risk for the composite of adaptive scales.

    Time frame: 5.5 years of age

  8. Executive Functioning

    Executive Functioning as measured by parent-report using the Behavioral Rating Inventory of Executive Function (BRIEF). T-scores have a mean of 50 and a standard deviation of 10. Higher scores indicate a potential problematic area of clinical significance.

    Time frame: 5.5 years of age

  9. Sensory Processing

    Sensory Processing related to auditory, visual, touch, movement, body position and oral processing as measured by parent-report using the Sensory Profile Second Edition (Sensory Profile-2). Higher scores indicating higher sensitivity in each category.

    Time frame: 5.5 years of age

  10. Gross Motor Development

    Measured using the assessor-administered Movement Assessment Battery for Children Second Edition (Movement ABC-2). Higher scores indicate superior performance.

    Time frame: 5.5 years of age

  11. Influence of the diet on epigenetic changes

    Assessed using a buccal cell biorepository.

    Time frame: 5.5 years of age

  12. Influence of genetics on taste

    Assessed using a buccal cell biorepository.

    Time frame: 5.5 years of age

  13. Fatty acid status

    Assessed using a buccal cell biorepository.

    Time frame: 5.5 years of age

  14. Children's eating behaviours and dietary intake

    Assessed using direct observation during a standardized lunch protocol.

    Time frame: 5.5 years of age

  15. Children's eating behaviours

    Assessed by parent-report using the Child Eating Behaviour Questionnaire (CEBQ). The CEBQ is made up of eight scales: Food responsiveness, Emotional over-eating, Enjoyment of food, Desire to drink, Satiety responsiveness, Slowness in eating, Emotional under-eating, and Food fussiness. Higher scores indicate higher frequency behaviour.

    Time frame: 5.5 years of age

  16. Food parenting and parent dietary intake

    Assessed using direct observation during a standardized lunch protocol.

    Time frame: 5.5 years of age

  17. Food parenting

    Assessed by parent-report using the Comprehensive Feeding Practices Questionnaire (CFPQ). The questionnaire contains 12 scales: 'Encourage Balance and Variety', 'Environment', 'Involvement', 'Modeling', 'Monitoring', 'Teaching about Nutrition', 'Emotion Regulation', 'Food as Reward', 'Pressure', 'Child Control', 'Restriction for Health' and 'Restriction for Weight Control'; higher scores indicate higher frequency behaviour.

    Time frame: 5.5 years of age

  18. Composition and community structure of the gastrointestinal microbiota

    High-throughput sequencing of microbial DNA from stool samples

    Time frame: 5.5 years of age

  19. Parent and child stress

    Measured using cortisol levels obtained from hair samples collected from both parent and child at the posterior vertex.

    Time frame: 5.5 years of age

  20. Parental stress

    Measured by parent-report using the Parent Distress sub-scale of the Parenting Stress Index Short Form (PSI-SF). Higher scores indicate higher levels of parental distress.

    Time frame: 5.5 years of age

  21. Home environment- Family Functioning

    Family functioning will be measured by parent-report using the General Functioning sub-scale of the Family Assessment Device (FAD). Higher scores indicate lower levels of functioning (problem solving, communication, etc.).

    Time frame: 5.5 years of age

  22. Home environment- Home Chaos

    Home Chaos will be measured by parent-report using the Confusion, Hubbub and Order Scale (CHAOS). Higher scores indicate a more chaotic home environment.

    Time frame: 5.5 years of age

07

Study locations

1 site
  • The Hospital for Sick Children
    Toronto, Ontario M5G 0A4, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 31, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04308902
Lead sponsor
The Hospital for Sick Children
Collaborators
Sinai Health System, University of Toronto
Responsible party
Deborah O'Connor (Senior Associate Scientist, The Hospital for Sick Children) — Principal investigator
First posted
Mar 16, 2020
Start date
Mar 12, 2020
Primary completion
Dec 1, 2021
Completion
Dec 1, 2021
Last update
Mar 31, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion